GTC
TEVA icon

Ghost Tree Capital’s Teva Pharmaceuticals TEVA Stock Holding History

Ghost Tree Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-100,000
Closed -$5.35M – 79
2016
Q1 		$5.35M Buy
+100,000
New +$5.87M 3.03% 12
2014
Q2 		– Sell
-150,000
Closed -$7.93M – 73
2014
Q1 		$7.93M Buy
150,000
+50,000
+50% +$2.31M 4.71% 3
2013
Q4 		$4.01M Buy
+100,000
New +$3.94M 2.47% 11

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ghost Tree Capital's TEVA Position: Q3 2014 in Review

Ghost Tree Capital sold out of Teva Pharmaceuticals (TEVA) in Q3 2014, closing a stake of 100,000 shares — an estimated $5.24M sold.

Ghost Tree Capital first reported a position in TEVA in Q2 2014 and held it in 1 quarter. The position peaked at $5.24M in Q2 2014. 772 funds tracked by Wall St. Rank hold TEVA as of Q3 2014.

  • Ghost Tree Capital reported no remaining Teva Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • Ghost Tree Capital sold 100,000 Teva Pharmaceuticals shares in Q3 2014, an estimated $5.24M.
  • Ghost Tree Capital first reported a position in Teva Pharmaceuticals in Q2 2014 and held it in 1 quarter.
  • Ghost Tree Capital's Teva Pharmaceuticals position peaked at $5.24M in Q2 2014.
  • 772 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2014.

Based on Ghost Tree Capital's 13F filing for Q3 2014, filed 14 Nov 2014.